Colgate-Palmolive (CL) is a publicly traded Consumer Defensive sector company. As of August 16, 2026, CL trades at $91.98 with a market cap of $73.30B and a P/E ratio of 36.21. CL moved -1.05% today. Year to date, CL is +16.36%; over the trailing twelve months it is +8.62%. Its 52-week range spans $74.55 to $100.18. Analyst consensus is buy with an average price target of $99.77. Rallies surfaces CL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for CL combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $91.98 |
| Market Cap | $73.30B |
| P/E Ratio | 36.21 |
| EPS | $2.54 |
| Dividend Yield | 0.53% |
| 52-Week High | $100.18 |
| 52-Week Low | $74.55 |
| Volume | 2.42M |
| Avg Volume | 0 |
| Revenue (TTM) | $21.05B |
| Net Income | $2.16B |
| Gross Margin | 60.42% |
14 analysts cover CL: 0 strong buy, 9 buy, 5 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $99.77.